Cargando…

Dysplasia of the fibrous sheath with axonemal and centriolar defects combined with lack of mitochondrial activity as associated factors of ICSI failure in primary ciliary dyskinesia syndrome

Detalles Bibliográficos
Autores principales:	Pariz, Juliana R., Rané, Caroline, Drevet, Joel, Hallak, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2020
Materias:	Expert Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993943/ https://www.ncbi.nlm.nih.gov/pubmed/33621011 http://dx.doi.org/10.1590/S1677-5538.IBJU.2019.0362

Ejemplares similares

GPs Meet Rare Lung Disorders Task Force factsheet: primary ciliary dyskinesia
por: de Benedictis, Fernando M.
Publicado: (2015)

Mutations in axonemal dynein assembly factor DNAAF3 cause primary ciliary dyskinesia
por: Mitchison, Hannah M., et al.
Publicado: (2012)

Axonemal Symmetry Break, a New Ultrastructural Diagnostic Tool for Primary Ciliary Dyskinesia?
por: Blanco-Máñez, Rosana, et al.
Publicado: (2022)

Concise practice recommendations for the provision of andrological services and assisted reproductive technology for male infertility patients during the SARS-CoV-2 in Brazil
por: Hallak, Jorge, et al.
Publicado: (2020)

The Drosophila orthologue of the primary ciliary dyskinesia-associated gene, DNAAF3, is required for axonemal dynein assembly
por: zur Lage, Petra, et al.
Publicado: (2021)

Novel centriolar defects underlie a primary ciliary dyskinesia phenotype in an adenylate kinase 7 deficient ciliated epithelium
por: Sheridan, Jennifer, et al.
Publicado: (2023)

SARS-CoV-2 and Multi-Organ damage – What men's health specialists should know about the COVID-19 pathophysiology
por: Teixeira, Thiago A., et al.
Publicado: (2021)

Proteome of the central apparatus of a ciliary axoneme
por: Zhao, Lei, et al.
Publicado: (2019)

X-linked primary ciliary dyskinesia due to mutations in the cytoplasmic axonemal dynein assembly factor PIH1D3
por: Olcese, Chiara, et al.
Publicado: (2017)

Novel dynein axonemal assembly factor 1 mutations identified using whole-exome sequencing in patients with primary ciliary dyskinesia
por: Zhou, Lei, et al.
Publicado: (2020)

Centriolar satellites are required for efficient ciliogenesis and ciliary content regulation
por: Odabasi, Ezgi, et al.
Publicado: (2019)

Molecular basis for CPAP-tubulin interaction in controlling centriolar and ciliary length
por: Zheng, Xiangdong, et al.
Publicado: (2016)

EYS Is a Protein Associated with the Ciliary Axoneme in Rods and Cones
por: Alfano, Giovanna, et al.
Publicado: (2016)

Semi-Lethal Primary Ciliary Dyskinesia in Rats Lacking the Nme7 Gene
por: Šedová, Lucie, et al.
Publicado: (2021)

Diagnosis of primary ciliary dyskinesia
por: Olm, Mary Anne Kowal, et al.
Publicado: (2015)

Perspectives for Primary Ciliary Dyskinesia
por: Bukowy-Bieryllo, Zuzanna, et al.
Publicado: (2022)

Distinct Axonemal Processes Underlie Spontaneous and Stimulated Airway Ciliary Activity
por: Ma, Weiyuan, et al.
Publicado: (2002)

Ciliary reversal without rotation of axonemal structures in ctenophore comb plates
Publicado: (1981)

A centriolar FGR1 oncogene partner-like protein required for paraflagellar rod assembly, but not axoneme assembly in African trypanosomes
por: Harmer, Jane, et al.
Publicado: (2018)

Role of CSPP-L in recruitment of ciliopathy proteins to centriolar satellites and the ciliary transition zone
por: Patzke, S, et al.
Publicado: (2012)

TTLL12 is required for primary ciliary axoneme formation in polarized epithelial cells
por: Ceglowski, J., et al.
Publicado: (2023)

Diagnosis and management of primary ciliary dyskinesia
por: Lucas, Jane S, et al.
Publicado: (2014)

Diagnosis and management of primary ciliary dyskinesia
por: Werner, Claudius, et al.
Publicado: (2015)

Primary ciliary dyskinesia: mechanisms and management
por: Damseh, Nadirah, et al.
Publicado: (2017)

Mucus Plugging in Primary Ciliary Dyskinesia
por: Adaikalam, Stephanie, et al.
Publicado: (2023)

Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
por: Canitano, Roberto, et al.
Publicado: (2008)

Tiagabine: efficacy and safety in partial seizures – current status
por: Bauer, Jürgen, et al.
Publicado: (2008)

Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders
por: Kutcher, Stan, et al.
Publicado: (2005)

Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
por: Bishop, Jeffrey R, et al.
Publicado: (2008)

A review of ramelteon in the treatment of sleep disorders
por: Neubauer, David N
Publicado: (2008)

Monotherapy for partial epilepsy: focus on levetiracetam
por: Gambardella, Antonio, et al.
Publicado: (2008)

Optimizing levodopa therapy for Parkinson’s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective
por: Brooks, David J
Publicado: (2008)

Review of frovatriptan in the treatment of migraine
por: Kelman, Leslie
Publicado: (2008)

Rasagiline in treatment of Parkinson’s disease
por: Nayak, Lakshmi, et al.
Publicado: (2008)

COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features
por: Antonini, Angelo, et al.
Publicado: (2008)

Quetiapine monotherapy for bipolar depression
por: Thase, Michael E
Publicado: (2008)

Update on the use of pramipexole in the treatment of Parkinson’s disease
por: Constantinescu, Radu
Publicado: (2008)

Varenicline in the treatment of tobacco dependence
por: Fagerström, Karl, et al.
Publicado: (2008)

Review of the clinical evidence for interferon β 1a (Rebif(®)) in the treatment of multiple sclerosis
por: Manfredonia, Francesco, et al.
Publicado: (2008)

New treatment options for fibromyalgia: critical appraisal of duloxetine
por: Üçeyler, Nurcan, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_fsc7vkepfc5a4skidkml06a35o